Varex Imaging: Q3 Earnings Insights

Shares of Varex Imaging VREX fell 3.44% in after-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share decreased 183.33% year over year to ($0.20), which missed the estimate of ($0.01).

Revenue of $171,200,000 decreased by 12.96% from the same period last year, which beat the estimate of $171,090,000.

Looking Ahead

Varex Imaging hasn't issued any earnings guidance for the time being.

Q4 revenue expected between $155,000,000 and $170,000,000.

How To Listen To The Conference Call

Date: Aug 12, 2020

Time: 05:00 PM

ET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Finvestors.vareximaging.com%2Fnews-and-events%2Fevents-and-presentations%2Fdefault.aspx&eventid=2396496&sessionid=1&key=387AAE038ED9206E41474E8CC4062B34&regTag=&sourcepage=register

Recent Stock Performance

Company's 52-week high was at $33.00

52-week low: $14.27

Price action over last quarter: down 6.21%

Company Description

Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital flat panel image detectors, high voltage connectors, ionization chambers, and buckys among others. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors and high voltage connectors among others. It has manufacturing, research, and development operation in the United States, Europe, Philippines and China, and sales and service operations throughout the world.